Примери за използване на Sodium equivalent на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
STATEMENT OF ACTIVE SUBSTANCES 35.2 g monensin sodium(equivalent to 32.4 g monensin).
G of piperacillin sodium equivalent to 4 g of piperacillin and 0.5366 g of tazobactam sodium equivalent to 500 mg of tazobactam.
Each 5 mL vial contains patisiran sodium equivalent to 10 mg patisiran.
G tazobactam sodium equivalent to 0.500 g tazobactam and4.170 g piperacillin sodium equivalent to 4.00 g piperacillin.
Each mL contains patisiran sodium equivalent to 2 mg patisiran.
G piperacillin sodium equivalent to 4000 mg of piperacillin and 0.5366 g tazobactam sodium equivalent to 500 mg of tazobactam.
Each 5 ml vial contains nusinersen sodium equivalent to 12 mg nusinersen.
G of piperacillin sodium equivalent to 2 g of piperacillin and 0.2683 g of tazobactam sodium equivalent to 250 mg of tazobactam.
Each vial contains epoprostenol sodium equivalent to 1.5 mg epoprostenol.
QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard capsule contains simeprevir sodium equivalent to 150 mg of simeprevir.
Each tablet contains dolutegravir sodium equivalent to 50 mg dolutegravir and 300 mg lamivudine.
Each vial contains: imipenem monohydrate equivalent to 500 mg imipenem anhydrate and cilastatin sodium equivalent to 500 mg cilastatin.
Each capsule contains simeprevir sodium equivalent to 150 milligrams of simeprevir.
Each vial contains ceftazidime pentahydrate equivalent to 2 g ceftazidime and avibactam sodium equivalent to 0.5 g avibactam.
Each tablet contains dolutegravir sodium equivalent to 10 mg, 25 mg or 50 mg dolutegravir.
Each vial contains ceftolozane sulfate equivalent to 1 g ceftolozane and tazobactam sodium equivalent to 0.5 g tazobactam.
Each vial contains patisiran sodium equivalent to 10 mg patisiran formulated as lipid nanoparticles.
STATEMENT OF ACTIVE SUBSTANCE(S) Each vial contains ganciclovir sodium equivalent to 500 mg ganciclovir.
Each tablet contains dolutegravir sodium equivalent to 50 mg dolutegravir, 600 mg abacavir(as sulfate) and 300 mg lamivudine.
Each vial of powder for solution for infusion contains omeprazole sodium equivalent to 40 mg of omeprazole.
Injection vial contains piperacillin sodium equivalent to 4.0g of piperacillin and tazobactam sodium equivalent to 0.5g of tazobactam.
Each vial of 2 mL contains sugammadex sodium equivalent to 200 mg sugammadex.
Each Biktarvy tablet contains bictegravir sodium equivalent to 50 mg of bictegravir, 200 mg of emtricitabine and tenofovir alafenamide fumarate equivalent to 25 mg of tenofovir alafenamide.
Each film-coated tablet contains dolutegravir sodium equivalent to 10 mg dolutegravir.
Each 5 ml vial contains nusinersen sodium equivalent to 12 mg nusinersen(2.4 mg/ml).
Composition: Acitve substance in 1 vial:Cefoperazone sodium equivalent to 1 or 2 g Cefoperazone.
Each ml contains 200 mg volanesorsen sodium, equivalent to 190 mg volanesorsen.
Each hard capsule contains simeprevir sodium equivalent to 150 mg of simeprevir.
Each Lescol 40 mg capsule contains 42.12 mg fluvastatin sodium equivalent to 40 mg fluvastatin free acid.
Each Lescol XL 80 mg tablet contains 84.24 mg fluvastatin sodium equivalent to 80 mg fluvastatin free acid.